Butyrate as an effective treatment of congenital chloride diarrhea

Slides:



Advertisements
Similar presentations
Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro
Advertisements

Volume 117, Issue 4, Pages (October 1999)
Volume 149, Issue 2, Pages e2 (August 2015)
Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled.
Some Patients With Irritable Bowel Syndrome May Have Exocrine Pancreatic Insufficiency  John S. Leeds, Andrew D. Hopper, Reena Sidhu, Alison Simmonette,
Diet as a Therapy for Irritable Bowel Syndrome: Progress at Last
Urinary and fecal incontinence in nursing homes
Huiqin He, Zhinong Jiang, Leimin Sun  Gastroenterology 
Volume 144, Issue 5, Pages e3 (May 2013)
Volume 129, Issue 5, Pages (November 2005)
Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure  Stephen J.D. O'Keefe, Palle B. Jeppesen,
Volume 152, Issue 4, Pages (March 2017)
Charles D. Gerson, Mary-Joan Gerson 
Volume 150, Issue 7, Pages (June 2016)
Volume 133, Issue 2, Pages (August 2007)
Covering the Cover Gastroenterology
Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: A randomized trial  Roberto Berni Canani, MD, PhD, Rita Nocerino,
Role of Colonic Fermentation in the Perception of Colonic Distention in Irritable Bowel Syndrome and Functional Bloating  Michele Di Stefano, Emanuela.
Volume 130, Issue 3, Pages (March 2006)
Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure  Stephen J.D. O'Keefe, Palle B. Jeppesen,
Effectiveness of Hepatitis B Treatment in Clinical Practice
Outcomes Among Living Liver Donors
Volume 125, Issue 2, Pages (August 2003)
Covering the Cover Gastroenterology
Volume 132, Issue 1, Pages (January 2007)
Pushing the Pedal to the Metal: Should We Accelerate Infliximab Therapy for Patients With Severe Ulcerative Colitis?  Hans H. Herfarth, MD, PhD  Clinical.
Volume 129, Issue 4, Pages (October 2005)
Volume 124, Issue 4, Pages (April 2003)
Volume 152, Issue 6, Pages (May 2017)
Effect of the Prebiotic Oligofructose on Relapse of Clostridium difficile-Associated Diarrhea: A Randomized, Controlled Study  Stephen Lewis, Stephen.
Clinical Challenges and Images in GI
Short-Bowel Syndrome Clinical Gastroenterology and Hepatology
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 133, Issue 2, Pages (August 2007)
Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment  Edgardo Smecuol, Maria Ines Pinto Sanchez,
Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate  Jörg Hamacher,
Volume 130, Issue 2, Pages (February 2006)
Volume 150, Issue 2, Pages e8 (February 2016)
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
Volume 151, Issue 6, Pages (December 2016)
Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study  William J. Sandborn, William F. Stenson,
Severe Constipation Clinical Gastroenterology and Hepatology
Volume 149, Issue 7, Pages e2 (December 2015)
Volume 147, Issue 6, Pages e5 (December 2014)
Efficacy of Linaclotide for Patients With Chronic Constipation
Volume 153, Issue 4, Pages (October 2017)
Volume 152, Issue 4, Pages (March 2017)
Covering the Cover Gastroenterology
Enlightenment on liver lanthanum exposure
Volume 148, Issue 4, Pages e2 (April 2015)
Some Patients With Irritable Bowel Syndrome May Have Exocrine Pancreatic Insufficiency  John S. Leeds, Andrew D. Hopper, Reena Sidhu, Alison Simmonette,
Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome  Claudia I. Reinders, Max Herulf, Tryggve Ljung,
The Dawning of a New Editorial Board for Gastroenterology
Volume 132, Issue 1, Pages (January 2007)
Medical management of fecal incontinence
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Volume 151, Issue 4, Pages (October 2016)
Effect of Orlistat on Fecal Fat, Fecal Biliary Acids, and Colonic Cell Proliferation in Obese Subjects  Dennis J. Ahnen, Roberto Guerciolini, Jonathan.
Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled.
Liver Transplantation for Hepatocellular Carcinoma
Michelle Maria Pietzak  Gastroenterology 
Clinical Gastroenterology and Hepatology
Eradication Therapy for Helicobacter pylori
Volume 139, Issue 6, Pages e1 (December 2010)
Reply Gastroenterology
Electronic Clinical Challenges and Images in GI
Volume 152, Issue 4, Pages (March 2017)
The Future of Endoscopic Retrograde Cholangiopancreatography
Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment  Derek Gillen, Angela A. Wirz, Kenneth E.L.
Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility  Jeffrey M.
Presentation transcript:

Butyrate as an effective treatment of congenital chloride diarrhea Roberto Berni Canani, Gianluca Terrin, Pia Cirillo, Giuseppe Castaldo, Francesco Salvatore, Giuseppe Cardillo, Anna Coruzzo, Riccardo Troncone  Gastroenterology  Volume 127, Issue 2, Pages 630-634 (August 2004) DOI: 10.1053/j.gastro.2004.03.071

Figure 1 Clinical efficacy of butyrate therapy in the child with congenital chloride diarrhea. Daily number of bowel movements (A) and stool volume (B) during the first week of baseline data collection and the subsequent 3 weeks of treatment with increasing doses of butyrate. Horizontal lines represent median values of each study week. ■, untreated; ▴, 50; ▾, 75; , 100 butyrate (mg/kg per day). Gastroenterology 2004 127, 630-634DOI: (10.1053/j.gastro.2004.03.071)

Figure 2 Effect of butyrate therapy on fecal electrolyte content. Fecal electrolyte concentrations (mEq/L) during the first week of baseline data collection and the subsequent 3 weeks of treatment with increasing doses of butyrate. Ion concentrations of 1 stool sample per day are reported. Horizontal lines indicate median values of each study week. ■, untreated; ▴, 50; ▾, 75; , 100 butyrate (mg/kg per day). Gastroenterology 2004 127, 630-634DOI: (10.1053/j.gastro.2004.03.071)

Figure 3 Rectal dialysis study. Intestinal electrolyte transport before (baseline) and during butyrate therapy (at 100 mg/kg/day) in the child affected by congenital chloride diarrhea. Gastroenterology 2004 127, 630-634DOI: (10.1053/j.gastro.2004.03.071)